Previous Article | Next Article ![]()
J Bacteriol, February 1998, p. 473-477, Vol. 180, No. 3
Institute Cantacuzino, 70100 Bucharest,
Romania,1 and
Laboratoire de Chimie
Structurale des Macromolécules,2
Laboratoire de l'Hybridolab,3 and
Unité de Régulation de l'Expression
Génétique,4 Institut
Pasteur, 75724 Paris Cedex 15, France
Received 13 October 1997/Accepted 20 November 1997
UMP kinase from Escherichia coli is one of the four
regulatory enzymes involved in the de novo biosynthetic pathway of
pyrimidine nucleotides. This homohexamer, with no counterpart in
eukarya, might serve as a target for new antibacterial drugs. Although the bacterial enzyme does not show sequence similarity with any other
known nucleoside monophosphate kinase, two segments between amino acids
35 to 78 and 145 to 194 exhibit 28% identity with phosphoglycerate
kinase and 30% identity with aspartokinase, respectively. Based on
these similarities, a number of residues of E. coli UMP kinase were selected for site-directed mutagenesis experiments. Biochemical, kinetic, and spectroscopic analysis of the modified proteins identified residues essential for catalysis (Asp146), binding
of UMP (Asp174), and interaction with the allosteric effectors, GTP and
UTP (Arg62 and Asp77).
0021-9193/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Mutational Analysis of UMP Kinase from
Escherichia coli
*
Corresponding author. Mailing address: Laboratoire de
Chimie Structurale des Macromolécules, 28, rue du Docteur Roux,
75724 Paris Cedex 15, France. Phone and fax: 33 (1) 45 68 84 05. E-mail: obarzu{at}pasteur.fr.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»